{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T19:39:40Z","timestamp":1785267580493,"version":"3.55.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T00:00:00Z","timestamp":1588723200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/j.clinthera.2020.04.014","type":"journal-article","created":{"date-parts":[[2020,7,2]],"date-time":"2020-07-02T08:11:56Z","timestamp":1593677516000},"page":"1246-1275.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparison of Therapies for Secondary Prophylaxis of Esophageal Variceal Bleeding in Cirrhosis: A Network Meta-analysis of Randomized Controlled Trials"],"prefix":"10.1016","volume":"42","author":[{"given":"Zhiwei","family":"Miao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bai","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingjia","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.04.014_bib1","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1056\/NEJM198810133191505","article-title":"Prediction of the first variceal hemorrhage in patients with cirrhosis of the liver and esophageal varices. A prospective multicenter study","volume":"319","year":"1988","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2020.04.014_bib2","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/S0140-6736(03)12778-X","article-title":"Prevention of variceal rebleeding","volume":"361","author":"Bosch","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.04.014_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jhep.2015.05.022","article-title":"Expanding consensus in portal hypertension: report of the Baveno VI Consensus Workshop: stratifying risk and individualizing care for portal hypertension","volume":"63","author":"de Franchis","year":"2015","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1002\/hep.28906","article-title":"Portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the Study of Liver Diseases","volume":"65","author":"Garcia-Tsao","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib5","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1136\/gut.2008.171207","article-title":"Nadolol plus isosorbide mononitrate alone or associated with band ligation in the prevention of recurrent bleeding: a multicentre randomised controlled trial","volume":"58","author":"Garcia-Pagan","year":"2009","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2020.04.014_bib6","first-page":"283","article-title":"Propranolol, isosorbide mononitrate and endoscopic band ligation\u2014alone or in varying combinations for the prevention of esophageal variceal rebleeding","volume":"19","author":"Ahmad","year":"2009","journal-title":"J\u00a0Coll Physicians Surgeons\u2014Pakistan"},{"key":"10.1016\/j.clinthera.2020.04.014_bib7","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1111\/j.1440-1746.2009.05792.x","article-title":"A\u00a0randomized, controlled trial of banding ligation plus drug therapy versus drug therapy alone in the prevention of esophageal variceal rebleeding","volume":"24","author":"Lo","year":"2009","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib8","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.1056\/NEJMoa0910102","article-title":"Early use of TIPS in patients with cirrhosis and variceal bleeding","volume":"362","author":"Garcia-Pagan","year":"2010","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2020.04.014_bib9","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1002\/hep.28318","article-title":"Covered transjugular intrahepatic portosystemic shunt versus endoscopic therapy\u00a0+ beta-blocker for prevention of variceal rebleeding","volume":"63","author":"Holster","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib10","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1136\/gutjnl-2017-314634","article-title":"Covered TIPS versus endoscopic band ligation plus propranolol for the prevention of variceal rebleeding in cirrhotic patients with portal vein thrombosis: a randomised controlled trial","volume":"67","author":"Lv","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2020.04.014_bib11","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1002\/hep.1840360612","article-title":"Randomized comparison of long-term carvedilol and propranolol administration in the treatment of portal hypertension in cirrhosis","volume":"36","author":"Banares","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib12","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1046\/j.1365-2036.2002.01190.x","article-title":"Haemodynamic effects of acute and chronic administration of low-dose carvedilol, a vasodilating beta-blocker, in patients with cirrhosis and portal hypertension","volume":"16","author":"Tripathi","year":"2002","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2020.04.014_bib13","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1111\/j.1440-1746.2012.07244.x","article-title":"Randomized, controlled trial of carvedilol versus nadolol plus isosorbide mononitrate for the prevention of variceal rebleeding","volume":"27","author":"Lo","year":"2012","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jclinepi.2017.10.005","article-title":"Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis","volume":"93","author":"Brignardello-Petersen","year":"2018","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Bmj"},{"key":"10.1016\/j.clinthera.2020.04.014_bib16","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1002\/sim.1875","article-title":"Combination of direct and indirect evidence in mixed treatment comparisons","volume":"23","author":"Lu","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2020.04.014_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1002\/1097-0258(20010215)20:3<453::AID-SIM803>3.0.CO;2-L","article-title":"Bayesian methods of analysis for cluster randomized trials with binary outcome data","volume":"20","author":"Turner","year":"2001","journal-title":"Stat Med"},{"key":"10.1016\/j.clinthera.2020.04.014_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jclinepi.2010.03.016","article-title":"Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial","volume":"64","author":"Salanti","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.jclinepi.2010.07.017","article-title":"GRADE guidelines: 4. Rating the quality of evidence\u2014study limitations (risk of bias)","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib20","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.jclinepi.2011.01.011","article-title":"GRADE guidelines: 5. Rating the quality of evidence\u2014publication bias","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib21","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.jclinepi.2011.01.012","article-title":"GRADE guidelines 6. Rating the quality of evidence\u2014imprecision","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib22","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence\u2014inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib23","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/j.jclinepi.2011.04.014","article-title":"GRADE guidelines: 8. Rating the quality of evidence\u2014indirectness","volume":"64","author":"Guyatt","year":"2011","journal-title":"J\u00a0Clin Epidemiol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib24","doi-asserted-by":"crossref","first-page":"g5630","DOI":"10.1136\/bmj.g5630","article-title":"A\u00a0GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis","volume":"349","author":"Puhan","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.clinthera.2020.04.014_bib25","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0168-8278(05)80585-9","article-title":"A\u00a0prospective randomized study to evaluate propranolol in patients undergoing long-term endoscopic sclerotherapy","volume":"19","author":"Acharya","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib26","doi-asserted-by":"crossref","first-page":"157-63","DOI":"10.1016\/S0016-5107(00)70411-1","article-title":"Variceal band ligation and variceal band ligation plus sclerotherapy in the prevention of recurrent variceal bleeding in cirrhotic patients: a randomized, prospective and controlled trial","volume":"51","author":"Argonz","year":"2000","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clinthera.2020.04.014_bib27","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S0168-8278(97)80112-2","article-title":"Endoscopic sclerotherapy versus variceal ligation in the long-term management of patients with cirrhosis after variceal bleeding. A prospective randomized study","volume":"26","author":"Avgerinos","year":"1997","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0168-8278(05)80586-0","article-title":"Propranolol in the prevention of recurrent upper gastrointestinal bleeding in patients with cirrhosis undergoing endoscopic sclerotherapy. A randomized controlled trial","volume":"19","author":"Avgerinos","year":"1993","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib29","doi-asserted-by":"crossref","first-page":"832-9","DOI":"10.1053\/gast.1996.v110.pm8608893","article-title":"Transjugular intrahepatic portosystemic shunt versus sclerotherapy in the elective treatment of variceal hemorrhage","volume":"110","author":"Cabrera","year":"1996","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib30","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-126-11-199706010-00002","article-title":"Endoscopic sclerotherapy compared with percutaneous transjugular intrahepatic portosystemic shunt after initial sclerotherapy in patients with acute variceal hemorrhage. A randomized, controlled trial","volume":"126","author":"Cello","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2020.04.014_bib31","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/hep.1840160116","article-title":"A\u00a0prospective randomized trial comparing repeated endoscopic sclerotherapy and propranolol in decompensated (Child class B and C) cirrhotic patients","volume":"16","author":"Dasarathy","year":"1992","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib32","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/hep.20584","article-title":"Variceal ligation plus nadolol compared with ligation for prophylaxis of variceal rebleeding: a multicenter trial","volume":"41","author":"de la Pena","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib33","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1053\/jhep.2002.30418","article-title":"TIPS versus drug therapy in preventing variceal rebleeding in advanced cirrhosis: a randomized controlled trial","volume":"35","author":"Escorsell","year":"2002","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib34","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1002\/hep.1840070224","article-title":"Prevention of recurrent bleeding in cirrhotics with recent variceal hemorrhage: prospective, randomized comparison of propranolol and sclerotherapy","volume":"7","author":"Fleig","year":"1987","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1002\/hep.510290125","article-title":"Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal rebleeding after recent variceal hemorrhage","volume":"29","author":"Garcia-Villarreal","year":"1999","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib36","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1053\/jhep.2000.8106","article-title":"Isosorbide mononitrate and propranolol compared with propranolol alone for the prevention of variceal rebleeding","volume":"31","author":"Gournay","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib37","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1080\/003655202317284255","article-title":"Transjugular intrahepatic portosystemic shunting is not superior to endoscopic variceal band ligation for prevention of variceal rebleeding in cirrhotic patients: a randomized, controlled trial","volume":"37","author":"Gulberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib38","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1440-1746.2010.06265.x","article-title":"Endoscopic band ligation plus argon plasma coagulation versus scleroligation for eradication of esophageal varices","volume":"25","author":"Harras","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib39","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/003655299750024841","article-title":"The rebleeding course and long-term outcome of esophageal variceal hemorrhage after ligation: comparison with sclerotherapy","volume":"34","author":"Hou","year":"1999","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1067\/mge.2001.114058","article-title":"A\u00a0new \u201csandwich\u201d method of combined endoscopic variceal ligation and sclerotherapy versus ligation alone in the treatment of esophageal variceal bleeding: a randomized trial","volume":"53","author":"Hou","year":"2001","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clinthera.2020.04.014_bib41","first-page":"1115","article-title":"A\u00a0randomized trial comparing transjugular intrahepatic portosystemic stent-shunt with variceal band ligation in the prevention of rebleeding from esophageal varices","volume":"26","author":"Jalan","year":"1997","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib42","doi-asserted-by":"crossref","first-page":"339","DOI":"10.3109\/00365528909093057","article-title":"Propranolol in prevention of rebleeding from oesophageal varices during the course of endoscopic sclerotherapy","volume":"24","author":"Jensen","year":"1989","journal-title":"Scand J Gastroenterol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib43","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1053\/j.gastro.2009.05.049","article-title":"Addition of propranolol and isosorbide mononitrate to endoscopic variceal ligation does not reduce variceal rebleeding incidence","volume":"137","author":"Kumar","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1053\/jhep.2000.16236","article-title":"Endoscopic variceal ligation plus nadolol and sucralfate compared with ligation alone for the prevention of variceal rebleeding: a prospective, randomized trial","volume":"32","author":"Lo","year":"2000","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib45","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/j.1440-1746.1993.tb01528.x","article-title":"Does propranolol maintain post-sclerotherapy variceal obliteration? A prospective randomized study","volume":"8","author":"Lo","year":"1993","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib46","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1053\/gast.2002.35351","article-title":"Banding ligation versus nadolol and isosorbide mononitrate for the prevention of esophageal variceal rebleeding","volume":"123","author":"Lo","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib47","first-page":"711","article-title":"Evaluation of propranolol for prevention of recurrent bleeding from esophageal varices between sclerotherapy sessions","volume":"156","author":"Lundell","year":"1990","journal-title":"Acta chirurgica Scand"},{"key":"10.1016\/j.clinthera.2020.04.014_bib48","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.gie.2016.12.026","article-title":"Randomized controlled trial of scleroligation versus band ligation alone for eradication of gastroesophageal varices","volume":"86","author":"Mansour","year":"2017","journal-title":"Gastrointest Endosc"},{"key":"10.1016\/j.clinthera.2020.04.014_bib49","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.510270109","article-title":"Transjugular intrahepatic portosystemic shunt versus endoscopic sclerotherapy for the prevention of variceal bleeding in cirrhosis: a randomized multicenter trial. Gruppo Italiano Studio TIPS (G.I.S.T.)","volume":"27","author":"Merli","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib50","doi-asserted-by":"crossref","first-page":"189-98","DOI":"10.1016\/S1386-6346(01)00104-8","article-title":"A\u00a0randomized clinical trial comparing transjugular intrahepatic portosystemic shunt with endoscopic sclerotherapy in the long-term management of patients with cirrhosis after recent variceal hemorrhage","volume":"21","author":"Narahara","year":"2001","journal-title":"Hepatol Res"},{"key":"10.1016\/j.clinthera.2020.04.014_bib51","first-page":"899","article-title":"Comparison of three nonsurgical treatments for bleeding esophageal varices","volume":"96","author":"O'Connor","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib52","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1053\/gast.2002.35955","article-title":"A\u00a0randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis","volume":"123","author":"Patch","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib53","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1136\/gut.48.3.390","article-title":"Transjugular intrahepatic portosystemic shunt (TIPS) versus endoscopic variceal ligation in the prevention of variceal rebleeding in patients with cirrhosis: a randomised trial","volume":"48","author":"Pomier-Layrargues","year":"2001","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2020.04.014_bib54","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/j.1365-2036.2006.03007.x","article-title":"Comparative study between nadolol and 5-isosorbide mononitrate vs. endoscopic band ligation plus sclerotherapy in the prevention of variceal rebleeding in cirrhotic patients: a randomized controlled trial","volume":"24","author":"Romero","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2020.04.014_bib55","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0168-8278(91)90828-Y","article-title":"Prevention of recurrent variceal bleeding in alcoholic cirrhotic patients: prospective controlled trial of propranolol and sclerotherapy","volume":"12","author":"Rossi","year":"1991","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib56","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(96)08189-5","article-title":"Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding","volume":"349","author":"R\u00f6ssle","year":"1997","journal-title":"The Lancet"},{"key":"10.1016\/j.clinthera.2020.04.014_bib57","doi-asserted-by":"crossref","first-page":"849","DOI":"10.7326\/0003-4819-126-11-199706010-00001","article-title":"Transjugular intrahepatic portosystemic shunts compared with endoscopic sclerotherapy for the prevention of recurrent variceal hemorrhage. A randomized, controlled trial","volume":"126","author":"Sanyal","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clinthera.2020.04.014_bib58","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1055\/s-2002-33565","article-title":"Endoscopic variceal ligation plus propranolol vs. transjugular intrahepatic portosystemic stent shunt: a long-term randomized trial","volume":"34","author":"Sauer","year":"2002","journal-title":"Endoscopy"},{"key":"10.1016\/j.clinthera.2020.04.014_bib59","doi-asserted-by":"crossref","first-page":"1623-31","DOI":"10.1053\/gast.1997.v113.pm9352865","article-title":"Transjugular intrahepatic portosystemic stent shunt versus sclerotherapy plus propranolol for variceal rebleeding","volume":"113","author":"Sauer","year":"1997","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib60","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2015.05.011","article-title":"Prevention of rebleeding from esophageal varices in patients with cirrhosis receiving small-diameter stents versus hemodynamically controlled medical therapy","volume":"149","author":"Sauerbruch","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib61","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2014.06.015","article-title":"Multicentre randomised controlled study comparing carvedilol with variceal band ligation in the prevention of variceal rebleeding","volume":"61","author":"Stanley","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib62","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1016\/0016-5085(93)90158-9","article-title":"Propranolol versus sclerotherapy in preventing variceal rebleeding: a randomized controlled trial","volume":"105","author":"Teres","year":"1993","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib63","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1056\/NEJM199606203342502","article-title":"Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding","volume":"334","author":"Villanueva","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2020.04.014_bib64","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1056\/NEJMoa003223","article-title":"Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding","volume":"345","author":"Villanueva","year":"2001","journal-title":"New Engl J Med"},{"issue":"Suppl 2","key":"10.1016\/j.clinthera.2020.04.014_bib65","doi-asserted-by":"crossref","first-page":"42","DOI":"10.2165\/00003495-198900372-00008","article-title":"Comparison of propranolol with injection sclerotherapy in prevention of rebleeding from oesophageal varices in cirrhotic patients","volume":"37","author":"Westaby","year":"1989","journal-title":"Drugs"},{"key":"10.1016\/j.clinthera.2020.04.014_bib66","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1136\/gut.38.5.770","article-title":"Sclerotherapy versus sclerotherapy and propranolol in the prevention of rebleeding from oesophageal varices: a randomised study","volume":"38","author":"Elsayed","year":"1996","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2020.04.014_bib67","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/archsurg.136.1.17","article-title":"Transjugular intrahepatic portasystemic shunt vs surgical shunt in good-risk cirrhotic patients: a case-control comparison","volume":"136","author":"Helton","year":"2001","journal-title":"Arch Surg (Chicago, Ill: 1960)"},{"key":"10.1016\/j.clinthera.2020.04.014_bib68","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/bjs.10431","article-title":"Outcomes of surgical shunts and transjugular intrahepatic portasystemic stent shunts for complicated portal hypertension","volume":"104","author":"Hosokawa","year":"2017","journal-title":"Br J Surg"},{"key":"10.1016\/j.clinthera.2020.04.014_bib69","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s00464-003-8196-8","article-title":"Modified devascularization surgery for isolated gastric varices assessed by endoscopic ultrasonography","volume":"18","author":"Hsieh","year":"2004","journal-title":"Surg Endosc"},{"key":"10.1016\/j.clinthera.2020.04.014_bib70","first-page":"162","article-title":"Sclerotherapy superior to surgery for longer survival and less rebleeding in 103 cirrhotics with variceal bleeding","volume":"74","author":"Kitano","year":"1989","journal-title":"Int Surg"},{"key":"10.1016\/j.clinthera.2020.04.014_bib71","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1055\/s-2008-1055398","article-title":"Narrow-lumen mesocaval interposition shunt in liver cirrhosis and recurrent esophageal varices hemorrhage. Standard surgery of the future in failure of sclerotherapy?","volume":"120","author":"Paquet","year":"1995","journal-title":"Deutsche medizinische Wochenschrift (1946)"},{"key":"10.1016\/j.clinthera.2020.04.014_bib72","doi-asserted-by":"crossref","first-page":"S391","DOI":"10.14309\/00000434-201110002-01048","article-title":"Cyanoacrylate injection for gastric varices can be performed safely with fluoroscopic guidance","volume":"106","author":"Qureshi","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib73","doi-asserted-by":"crossref","first-page":"1538-47","DOI":"10.1007\/s10620-005-2877-1","article-title":"Evaluation of endoscopic variceal ligation (EVL) versus propranolol plus isosorbide mononitrate\/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients","volume":"50","author":"Sarin","year":"2005","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.clinthera.2020.04.014_bib74","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/S0168-8278(94)80141-X","article-title":"Prevention of rebleeding from oesophageal varices: two-year follow up of a prospective controlled trial of propranolol in addition to sclerotherapy","volume":"21","author":"Vickers","year":"1994","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib75","doi-asserted-by":"crossref","first-page":"1760-3","DOI":"10.1016\/0016-5085(92)91740-U","article-title":"Propranolol reduces the rebleeding rate during endoscopic sclerotherapy before variceal obliteration","volume":"102","author":"Vinel","year":"1992","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib76","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1136\/gut.29.6.752","article-title":"Effect and mechanism of action of isosorbide-5-mononitrate","volume":"29","author":"Hayes","year":"1988","journal-title":"Gut"},{"key":"10.1016\/j.clinthera.2020.04.014_bib77","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1016\/0016-5085(89)91630-2","article-title":"Reduction of portal pressure by isosorbide-5-mononitrate in patients with cirrhosis. Effects on splanchnic and systemic hemodynamics and liver function","volume":"96","author":"Navasa","year":"1989","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib78","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/S0168-8278(99)80108-1","article-title":"Acute and chronic haemodynamic and renal effects of carvedilol in patients with cirrhosis","volume":"30","author":"Stanley","year":"1999","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.clinthera.2020.04.014_bib79","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/apt.12634","article-title":"Systematic review with meta-analysis: the haemodynamic effects of carvedilol compared with propranolol for portal hypertension in cirrhosis","volume":"39","author":"Sinagra","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2020.04.014_bib80","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/hep.23775","article-title":"Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites","volume":"52","author":"Serste","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib81","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/hep.20766","article-title":"Circulatory function and hepatorenal syndrome in cirrhosis","volume":"42","author":"Ruiz-del-Arbol","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.clinthera.2020.04.014_bib82","first-page":"Cd000553","article-title":"Portosystemic shunts versus endoscopic therapy for variceal rebleeding in patients with cirrhosis","author":"Khan","year":"2006","journal-title":"Cochrane database Syst Rev"},{"key":"10.1016\/j.clinthera.2020.04.014_bib83","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s10620-014-3150-2","article-title":"Efficacy of transjugular intrahepatic portosystemic shunt with adjunctive embolotherapy with cyanoacrylate for esophageal variceal bleeding","volume":"59","author":"Shi","year":"2014","journal-title":"Dig Dis Sci"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820302320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820302320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:52:39Z","timestamp":1758963159000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291820302320"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":83,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S0149291820302320"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.04.014","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Therapies for Secondary Prophylaxis of Esophageal Variceal Bleeding in Cirrhosis: A Network Meta-analysis of Randomized Controlled Trials","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.04.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}